| 摘要 |
Provided are substituted quinazolin-4-one compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein R1,R2,R3,R5,R6 and L are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the class I PI3K kinases. |
| 申请人 |
NOVARTIS AG;DU, ZHENXING;HINTERMANN, SAMUEL;HURTH, KONSTANZE;JACQUIER, SEBASTIEN;LEHMANN, HANSJOERG;MOEBITZ, HENRIK;SOLDERMANN, NICOLAS;STOJANOVIC, ALEKSANDAR |
发明人 |
DU, ZHENXING;HINTERMANN, SAMUEL;HURTH, KONSTANZE;JACQUIER, SEBASTIEN;LEHMANN, HANSJOERG;MOEBITZ, HENRIK;SOLDERMANN, NICOLAS;STOJANOVIC, ALEKSANDAR |
